A New View Duchenne Muscular Dystrophy
dystrophin, creatine kinase, metabolism, apoptosis
Abstract
Duchenne Muscular Dystrophy is the result of mutation gene-dystrophine, productprotein-dystrophin presents in organism as the complexes proteins placing everywhere, their role unclear. Suppose all dystrophine complexes work as one functional System D, thanks signal ability complexes. Suppose the System D the ancient and appeared when the gene dystrophin-utrophin divided into two genes dystrophin and utrophin at early vertebrates. Perfect this System made the gene the longest in human genome. The surprising activity creat inkinase-21-23 000 ME, found by author, make to think of the damage much membranesdamage System. Destroy System D is beginning of the disease, finishing apoptosis-general destructive factor. Two factors determinate the disease-damage the system D and apoptosis.
Downloads
How to Cite
References
L Kunkel (1986) Analysis of deletions in DNA from patients with Becker and Duchenn Muscular Dystrophy.
Eric Hoffman, Robert Brown, Louis Kunkel (1987) Dystrophin: The protein product of the duchenne muscular dystrophy locus. 51(6), 919-928.
Кoenigm Kunkel, L (1990) / detailed analysis of the rapid domain of dystrophin reveals four potential hinge segmsnts that may confer flexibility. 265(8), 4560-4566.
Rumeir Winder, S Hubert, J Dystrophin (2012) Unknown Title. 586, 2717-2719.
Derek Blake, Andrew Weir, Sarah Newey, Kay Davies (2002) Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle. 82(2), 291-329.
Lidovh, T Byers, L Kunkel (1990) The distribution of dystrophin in the murine central nervous system cortical neurons. 348, 72-78.
G Banks, P Gregorevic, J Allen, E Finn, J Chamberlain (2007) Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain. 16(17), 2105-2113.
B Niels, S Takedo, T Yokota (2015) Nonmechanicalrols of Dystrophin and associated proteins in exercise neuromuscular junctions and brain BrainSci. 5, 275-298.
V Sojos, M Curto, C Reali, F Gremo (2002) Developmentally regulated expression and localization of dystrophin and utropin in the human fetal brain. 123(5), 455-462.
Xaver Koenig, Janine Ebner, Karlheinz Hilber (2018) Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart. 19(11), 3296.
Maaike Van Putten, Elizabeth Van Der Pijl, Margriet Hulsker, Ingrid Verhaart, Vishna Nadarajah, Louise Van Der Weerd, Annemieke Aartsma-Rus (2014) Low dystrophin levels in heart can delay heart failure in mdx mice. 69, 17-23.
R Hendriksen, S Schipper, G Hoogland (2016) Dystrophin distribution and expression in human. 2, 174.
Waite Blaked, S Brown (2012) The dystrophinglucoprotein complex in brain development and disease. 35(8), 497-499.
Kevin Culligan, Louise Glover, Paul Dowling, Kay Ohlendieck (2991) Brain dystrophin-glycoprotein complex: Persistent expression of β-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy. 2(1).
Basil Darras, Caroline Menache-Starobinski, Veronica Hinton, Louis Kunkel (2011) Dystrophinopathies. 107, 551-592.
I Tracey, J Dunn, G Radda (1996) Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy. 119(3), 1039-1044.
R Wicksell, M Kihlgren (2004) Specific cognitive deficits are common in children with Duchenne Muscular Dystrophy. 46, 154.
M Sekiguochi, K Zushide, M Yoshida (2009) A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behavior in mice. 132(1), 1.
L Grinio (1998) A new hypothesis of duchenne muscular dystrophy. 1-100.
L Grinio (2019) The pathogenesis of Duchenne muscular dystrophy. 119(3), 79.
Yuka Morikawa, Todd Heallen, John Leach, Yang Xiao, James Martin (2017) Dystrophin-glycoprotein complex sequesters Yap to inhibit cardiomyocyte proliferation. 547(7662), 227-231.
Valeria Sogos, Monica Curto, Camilla Reali, Fulvia Gremo (2002) Developmentally regulated expression and localization of dystrophin and utrophin in the human fetal brain. 123(5), 455-462.
Nadia Milad, Zoe White, Arash Tehrani, Stephanie Sellers, Fabio Rossi, Pascal Bernatchez (2017) Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy. 7(1), 227-231.
Goodnough Gao, Y Qutaish, Q (2014) Lack dystrophin results in abnormal cerebral diffusion and perfusion in vivo. 192(2), 809-816.
A Gambardelle (2019) Dystrophin distribution and expression in human and experimental temporal lobe. 49-58.
T Haenggi, J-M Fritschy (2006) Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. 63(14), 1614-1631.
Kevin Culligan, Louise Glover, Paul Dowling, Kay Ohlendieck (2001) Brain dystrophin-glycoprotein complex: Persistent expression of β-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy. 2(1), 2-10.
Jeffery Goldstein, Elizabeth Mcnally (2010) Mechanisms of muscle weakness in muscular dystrophy. 136(1), 29-34.
Jennifer Anderson, Stewart Head, John Morley (2009) Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice. 1019(1-2), 289-292.
Y Ujhara (2020) Estimation of fukutin reveals cellular and molecular pathomechanims in muscular dystrophy. 10, 1038-1041.
S Vican, G Piccini, E Mercuri, P Alfieri (2018) Implacit learning deficit in children with Duchenne Muscular Dystrophy: evidence for a cerebellar cognitive impairtment. 10, 82.
A Pins, P Spitali (2015) Circulating biomarkers for Duchenne Muscular Dystrophy. 2, 49-58.
David Allen, Nicholas Whitehead, Stanley Froehner (2016) Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. 96(1), 253-305.
Simon Guiraud, Kay Davies (2019) Regenerative biomarkers for Duchenne muscular dystrophy. 14(8), 1317.
Miranda Grounds, Jessica Terrill, Basma Al-Mshhdani, Marisa Duong, Hannah Radley-Crabb, Peter Arthur (2020) Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. 13(2), 12-42.
S Savitz, B Daniel, M Rosenbaum (1998) Apoptosis in neurological siseases. 42, 555-572.
Mark Arends, Andrew Wyllie (1991) Apoptosis: Mechanisms and Roles in Pathology. 32, 223-254.
Ho Tang, Ho Tang, Keng Mak, Shaomin Hu, Shan Wang, Kit Wong, Chung Wong, Hoi Wu, Hiu Law, Kan Liu, C Talbot, Wan Lau, Denise Montell, Ming Fung (2012) Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. 23(12), 2240-2252.
G Borras (2006) Programmed cell death in plants and animals. 23, 1.
V Soyos, M Curto, C Reali, F Grenio (2002) Developmentally regulated expression and localization of dystrophin and utropin in the human fetal brain. 123(5), 455-462.
N Milad, Z White, A Tehrani, F Rossi (2017) Increased plasma lipid levels in the mdx model. 13, 227-231.
Kevin Culligan, Louise Glover, Paul Dowling, Kay Ohlendieck (2001) Brain dystrophin-glycoprotein complex: Persistent expression of β-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy. 2(1), 2-9.
Published
2021-10-04
Issue
Section
License
Copyright (c) 2021 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.